Status:
UNKNOWN
Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to examine if outcome after liver transplantation is improved by using albumin infusion post-transplantation.
Eligibility Criteria
Inclusion
- 18 years or older
- Canadian Transplant status 1 or 2
- Patients at the Royal Victoria Hospital, Montreal, Canada
Exclusion
- Emergency liver transplant (canadian transplant status 3 or 4)
- patients who have received more than 300cc of albumin within 48 hours prior to transplant
- patients who underwent previous solid organ transplant
- multi-organs transplant recipients
- patients who had previous adverse reaction to human albumin solution
- patients who have religious restriction to receiving human blood products.
- patients or surrogate unable to give consent to the study
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00842803
Start Date
January 1 2010
End Date
June 1 2012
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Victoria Hospital
Montreal, Quebec, Canada, H3A1A1